Your browser doesn't support javascript.
loading
CT radiomics compared to a clinical model for predicting checkpoint inhibitor treatment outcomes in patients with advanced melanoma.
Ter Maat, Laurens S; van Duin, Isabella A J; Elias, Sjoerd G; Leiner, Tim; Verhoeff, Joost J C; Arntz, Eran R A N; Troenokarso, Max F; Blokx, Willeke A M; Isgum, Ivana; de Wit, Geraldine A; van den Berkmortel, Franchette W P J; Boers-Sonderen, Marye J; Boomsma, Martijn F; van den Eertwegh, Fons J M; de Groot, Jan Willem B; Piersma, Djura; Vreugdenhil, Art; Westgeest, Hans M; Kapiteijn, Ellen; van Diest, Paul J; Pluim, Josien P W; de Jong, Pim A; Suijkerbuijk, Karijn P M; Veta, Mitko.
Afiliação
  • Ter Maat LS; Image Sciences Institute, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Electronic address: l.s.termaat@umcutrecht.nl.
  • van Duin IAJ; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Elias SG; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Leiner T; Department of Radiology, Mayo Clinical, Rochester, MN, USA.
  • Verhoeff JJC; Department of Radiotherapy, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Arntz ERAN; Utrecht University, Utrecht, the Netherlands.
  • Troenokarso MF; Utrecht University, Utrecht, the Netherlands.
  • Blokx WAM; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Isgum I; Departments of Biomedical Engineering and Physics & Radiology and Nuclear Medicine, University Medical Center Amsterdam, University of Amsterdam, Amsterdam, the Netherlands; Quantitative Healthcare Analysis group, Informatics Institute, Faculty of Science, University of Amsterdam, Amsterdam, the
  • de Wit GA; Department of Public Health, Healthcare Innovation & Evaluation and Medical Humanities, Julius Center Research Program Methodology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Center, Sittard-Geleen, the Netherlands.
  • Boers-Sonderen MJ; Department of Medical Oncology, Radboudumc, Radboud University, Nijmegen, the Netherlands.
  • Boomsma MF; Department of Radiology, Isala Zwolle, Zwolle, the Netherlands.
  • van den Eertwegh FJM; Department of medical oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Boelelaan 1117, Amsterdam, the Netherlands.
  • de Groot JWB; Isala Oncology Center, Isala Zwolle, Zwolle, the Netherlands.
  • Piersma D; Department of Medical Oncology, Medisch Spectrum Twente, Enschede, the Netherlands.
  • Vreugdenhil A; Department of Medical Oncology, Máxima Medical Center, Veldhoven, the Netherlands.
  • Westgeest HM; Department of Medical Oncology, Amphia Hospital, Breda, the Netherlands.
  • Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, Leiden University, Leiden, the Netherlands.
  • van Diest PJ; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Pluim JPW; Image Sciences Institute, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; Medical Image Analysis, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands.
  • de Jong PA; Department of Radiology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Veta M; Medical Image Analysis, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands.
Eur J Cancer ; 185: 167-177, 2023 05.
Article em En | MEDLINE | ID: mdl-36996627
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2023 Tipo de documento: Article